3,043
Views
195
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

, , , , , , , , , & show all
Pages 536-543 | Received 17 Oct 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Charlotta Wadsten, Hanna Heyman, Marit Holmqvist, Johan Ahlgren, Mats Lambe, Malin Sund & Fredrik Wärnberg. (2016) A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years. Acta Oncologica 55:11, pages 1338-1343.
Read now
Guo-Wei Qian, Xiao-Jian Ni, Zheng Wang, Yi-Zhou Jiang, Ke-Da Yu & Zhi-Ming Shao. (2015) Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis. OncoTargets and Therapy 8, pages 1407-1418.
Read now
Shivani Duggal, Julieta Robin & Thomas B Julian. (2013) Ductal carcinoma in situ: an overview. Expert Review of Anticancer Therapy 13:8, pages 955-962.
Read now
Benjamin D Smith, Grace L Smith & Thomas A Buchholz. (2008) Controversies over the role of radiation therapy for ductal carcinoma in situ. Expert Review of Anticancer Therapy 8:3, pages 433-441.
Read now
Tracey Irvine & Ian S Fentiman. (2007) Biology and treatment of ductal carcinoma in situ. Expert Review of Anticancer Therapy 7:2, pages 135-145.
Read now

Articles from other publishers (190)

Lye-Yeng Wong, Ntemena Kapula, Hao He, Brandon A. Guenthart, Lucas K. Vitzthum, Kathleen Horst, Douglas Z. Liou, Leah M. Backhus, Natalie S. Lui, Mark F. Berry, Joseph B. Shrager & Irmina A. Elliott. (2023) Risk of developing subsequent primary lung cancer after receiving radiation for breast cancer. JTCVS Open.
Crossref
Alexandra D. Dreyfuss, Danielle Max, Jessica Flynn, Zhigang Zhang, Erin F. Gillespie, Amy Xu, John Cuaron, Boris Mueller, Atif J. Khan, Oren Cahlon, Simon N. Powell, Beryl McCormick & Lior Z. Braunstein. (2023) Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ. Advances in Radiation Oncology 8:5, pages 101254.
Crossref
Amanda L. Nash & E. Shelley Hwang. (2023) The Landmark Series—Ductal Carcinoma in Situ: The Evolution of Treatment. Annals of Surgical Oncology 30:6, pages 3206-3214.
Crossref
David Dabbs, Karuna Mittal, Scott Heineman, Pat Whitworth, Chirag Shah, Jess Savala, Steven C. Shivers & Troy Bremer. (2023) Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ. Frontiers in Oncology 13.
Crossref
Siobhan Elizabeth Fitzpatrick, Michael Eaton, William McLeay & Nicola R. Dean. (2023) Outcomes of DCIS treated with breast conserving surgery without radiotherapy on recurrence, survival, and health‐related quality of life . ANZ Journal of Surgery.
Crossref
Sara Abdollahi, Mohammad Hadi Hadizadeh Yazdi, Ali Asghar Mowlavi, Sofie Ceberg, Marianne Camille Aznar, Fatemeh Varshoee Tabrizi, Roham Salek, Alireza Ghodsi & Ali Shams. (2023) A dose planning study for cardiac and lung dose sparing techniques in left breast cancer radiotherapy: Can free breathing helical tomotherapy be considered as an alternative for deep inspiration breath hold?. Technical Innovations & Patient Support in Radiation Oncology 25, pages 100201.
Crossref
Amanda L. Nash, Sabrina Wang, Susan McDuff & E. Shelley Hwang. (2023) De-escalation in DCIS Care. Current Breast Cancer Reports 15:1, pages 58-68.
Crossref
David J Dabbs, Richard S Huang & Jeffrey S Ross. (2022) Novel markers in breast pathology. Histopathology 82:1, pages 119-139.
Crossref
Laura K. Krecko, Meeghan A. Lautner & Lee G. Wilke. (2023) Clinical Trials That Have Informed the Modern Management of Breast Cancer. Surgical Oncology Clinics of North America 32:1, pages 27-46.
Crossref
Benjamin Silver, Sarah Mattessich, Irini Yacoub, Brian Rhee & David Schreiber. (2022) Patterns of Care and Utilization of Radiation for Women With Good-Risk Ductal Carcinoma In Situ: A National Cancer Database Analysis. Cureus.
Crossref
Yilan Yang, Xu Zhao, Xuanyi Wang, Kairui Jin, Jurui Luo, Zhaozhi Yang, Xin Mei, Jinli Ma, Zhimin Shao, Zhen Zhang, Xingxing Chen, Xiaomao Guo & Xiaoli Yu. (2022) Molecular subtypes predict second breast events of ductal carcinoma in situ after breast‐conserving surgery. Cancer Medicine 11:14, pages 2755-2766.
Crossref
Csaba Polgár, Zsuzsanna Kahán, Olivera Ivanov, Martin Chorváth, Andrea Ligačová, András Csejtei, Gabriella Gábor, László Landherr, László Mangel, Árpád Mayer & János Fodor. (2022) Radiotherapy of Breast Cancer—Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer. Pathology and Oncology Research 28.
Crossref
William J. GradisharMeena S. MoranJame AbrahamRebecca AftDoreen AgneseKimberly H. AllisonBethany AndersonHarold J. BursteinHelen ChewChau DangAnthony D. EliasSharon H. GiordanoMatthew P. GoetzLori J. GoldsteinSara A. HurvitzSteven J. IsakoffRachel C. JankowitzSara H. JavidJairam KrishnamurthyMarilyn LeitchJanice LyonsJoanne MortimerSameer A. PatelLori J. PierceLaura H. RosenbergerHope S. RugoAmy SitapatiKaren Lisa SmithMary Lou SmithHatem SolimanErica M. Stringer-ReasorMelinda L. TelliJohn H. WardKari B. WisinskiJessica S. Young, Jennifer BurnsRashmi Kumar. (2022) Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 20:6, pages 691-722.
Crossref
Marc Thill, Iris Szwarcfiter, Katharina Kelling, Viviane Haasteren, Eyal Kolka, Josefa Noelke, Zachi Peles, Moshe Papa, Sebastian Aulmann & Tanir Allweis. (2021) Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast‐conserving surgery—Results from a postmarketing study. Journal of Surgical Oncology 125:3, pages 361-368.
Crossref
Danielle Riley, Elizabeth A. Chrischilles, Ingrid M. Lizarraga, Mary Charlton, Brian J. Smith & Charles F. Lynch. (2022) Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000–2015. Breast Cancer Research and Treatment 192:1, pages 211-222.
Crossref
Fredrik Wärnberg, Per Karlsson, Erik Holmberg, Kerstin Sandelin, Pat W. Whitworth, Jess Savala, Todd Barry, Glen Leesman, Steven P. Linke, Steven C. Shivers, Frank Vicini, Chirag Shah, Sheila Weinmann, Gregory Bruce Mann & Troy Bremer. (2021) Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS). Cancers 13:23, pages 6103.
Crossref
Sarah Anderson, Elizabeth Parker, Habib Rahbar & John R. Scheel. (2021) IV Ductal Carcinoma In Situ, Including its Histologic Subtypes and Grades. Current Breast Cancer Reports 13:4, pages 398-404.
Crossref
Beryl McCormick, Kathryn A. Winter, Wendy Woodward, Henry M. Kuerer, Nour Sneige, Eileen Rakovitch, Barbara L. Smith, Isabelle Germain, Alan C. Hartford, Mark A. O'Rourke, Eleanor M. Walker, Eric A. Strom, Judith O. Hopkins, Lori J. Pierce, Anthony T. Pu, Kenneth N. M. Sumida, Danny Vesprini, Jennifer Moughan & Julia R. White. (2021) Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804. Journal of Clinical Oncology 39:32, pages 3574-3582.
Crossref
Maartje van Seijen, Esther H. Lips, Liping Fu, Daniele Giardiello, Frederieke van Duijnhoven, Linda de Munck, Lotte E. Elshof, Alastair Thompson, Elinor Sawyer, Marc D. Ryser, E. Shelley Hwang, Marjanka K. Schmidt, Paula H. M. Elkhuizen, Jelle Wesseling & Michael Schaapveld. (2021) Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast. British Journal of Cancer 125:10, pages 1443-1449.
Crossref
Mieke R. Van Bockstal, Louis Libbrecht & Christine Galant. (2021) The 5-Year Paradigm in DCIS of the Breast: Unexpected Lessons From the NSABP B-43 Trial. Journal of Clinical Oncology 39:30, pages 3409-3410.
Crossref
Charles E. Leonard, Shannon P. Tole, Michelle P. Turner, John P. Bennett, Kathryn T. Howell & Dennis L. Carter. (2021) Association of the 12-Gene Breast DCIS Score® Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols. Frontiers in Oncology 11.
Crossref
L. Kuntz, C. Le Fèvre, C. Hild, A. Keller, M. Gharbi, C. Mathelin, X. Pivot, G. Noël & D. Antoni. (2021) Survie globale et sans récidive locale en cas de radiothérapie du lit tumoral des carcinomes canalaires in situ du sein : revue de la littérature. Gynécologie Obstétrique Fertilité & Sénologie  49:4, pages 255-265.
Crossref
Libo Yang, Dongli Lu, Yutian Lai, Mengjia Shen, Qiuxiao Yu, Ting Lei, Tianjie Pu & Hong Bu. (2020) Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels. Annals of Surgical Oncology 28:2, pages 975-984.
Crossref
Vineeta Goel & Deepti Sharma. 2021. Management of Early Stage Breast Cancer. Management of Early Stage Breast Cancer 179 193 .
Brittany L. Murphy, Kelly K. Hunt & Sarah M. DeSnyder. 2021. Breast & Gynecological Diseases. Breast & Gynecological Diseases 137 156 .
Stuart J. Schnitt, Meena S. Moran & Armando E. Giuliano. (2020) Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact. Journal of Clinical Oncology 38:20, pages 2240-2245.
Crossref
M. J. Cambra, F. Moreno, X. Sanz, L. Anglada, M. Mollà, V. Reyes, M. Arenas, A. Pedro, R. Ballester, V. García, J. Casals, M. Cusidó, C. Jimenez, J. M. Escribà, M. Macià, J. M. Solé, A. Arcusa, M. A. Seguí, S. Gonzalez, B. Farrús & A. Biete. (2019) Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients. Clinical and Translational Oncology 22:5, pages 670-680.
Crossref
Carlotta Becherini, Icro Meattini, Lorenzo Livi, Pietro Garlatti, Isacco Desideri, Vieri Scotti, Lorenzo Orzalesi, Luis Jose Sanchez, Marco Bernini, Donato Casella, Silvia Nesi, Jacopo Nori, Simonetta Bianchi, Stefania Pallotta & Livia Marrazzo. (2018) External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial. Tumori Journal 105:3, pages 205-209.
Crossref
Icro Meattini, Matteo Lambertini, Isacco Desideri, Alex De Caluwé, Orit Kaidar-Person & Lorenzo Livi. (2019) Radiation therapy for young women with early breast cancer: Current state of the art. Critical Reviews in Oncology/Hematology 137, pages 143-153.
Crossref
Audree B. Tadros, Benjamin D. Smith, Yu Shen, Heather Lin, Savitri Krishnamurthy, Anthony Lucci, Carlos H. Barcenas, Rosa F. Hwang, Gaiane Rauch, Lumarie Santiago, Eric A. Strom, Sarah M. DeSnyder, Wei T. Yang, Dalliah M. Black, Constance T. Albarracin, Mariana Chavez-MacGregorKelly K. Hunt & Henry M. Kuerer. (2019) Ductal Carcinoma In Situ and Margins <2 mm. Annals of Surgery 269:1, pages 150-157.
Crossref
Anita Mamtani, Adriana D. Corben & Monica Morrow. 2019. Oncoplastic and Reconstructive Breast Surgery. Oncoplastic and Reconstructive Breast Surgery 233 246 .
Michelle S. Han & Seema A. Khan. (2018) Clinical Trials for Ductal Carcinoma In Situ of the Breast. Journal of Mammary Gland Biology and Neoplasia 23:4, pages 293-301.
Crossref
Aaron J. Grossberg, Xiudong Lei, Ting Xu, Simona F. Shaitelman, Karen E. Hoffman, Elizabeth S. Bloom, Michael C. Stauder, Welela Tereffe, Pamela J. Schlembach, Wendy A. Woodward, Thomas A. Buchholz & Benjamin D. Smith. (2018) Association of Transforming Growth Factor β Polymorphism C−509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer. JAMA Oncology 4:12, pages 1751.
Crossref
Esther Dubrovsky, Pauline Nguyen, Jennifer Chun, Shira Schwartz, Samantha Raymond, Amber Guth, Freya Schnabel & Naamit K. Gerber. (2018) Ductal carcinoma in situ on core needle biopsy only with no residual disease at surgery. The Breast Journal 24:6, pages 971-975.
Crossref
Sarah M. DeSnyder, Kelly K. Hunt, Wenli Dong, Benjamin D. Smith, Meena S. Moran, Mariana Chavez-MacGregor, Yu Shen, Henry M. Kuerer & Anthony Lucci. (2018) American Society of Breast Surgeons’ Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation. Annals of Surgical Oncology 25:10, pages 2965-2974.
Crossref
Rinaa S Punglia, Kaitlyn Bifolck, Mehra Golshan, Constance Lehman, Laura Collins, Kornelia Polyak, Elizabeth Mittendorf, Judy Garber, Shelley E Hwang, Stuart J Schnitt, Ann H Partridge & Tari A King. (2018) Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectrum 2:4.
Crossref
Qiuting You, Kai Chen, Yudong Li, Jianguo Lai, Yichao Fang, Shiyu Shen, Yicheng Liu, Fengxi Su & Fengyan Yu. (2018) Factors associated with the increasing trend of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ: Analysis of Surveillance, Epidemiology, and End Results data. The Breast 40, pages 147-155.
Crossref
C. Wadsten, A.-K. Wennstig, H. Garmo, Greger Nilsson, Carl Blomqvist, Lars Holmberg, Irma Fredriksson, F. Wärnberg & M. Sund. (2018) Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ. Breast Cancer Research and Treatment 171:1, pages 95-101.
Crossref
Ambrogio P. Londero, Serena Bertozzi, Roberta Di Vora, Fabrizio De Biasio, Luca Seriau, Pier Camillo Parodi, Lorenza Driul, Andrea Risaliti, Laura Mariuzzi & Carla Cedolini. 2018. Cancer Management and Therapy. Cancer Management and Therapy.
Ciara C. O'Sullivan, Charles L. Loprinzi & Tufia C. Haddad. (2018) Updates in the Evaluation and Management of Breast Cancer. Mayo Clinic Proceedings 93:6, pages 794-807.
Crossref
Pankaj Kumar Garg, Ashish Jakhetiya, Rambha Pandey, Nilokali Chishi & Durgatosh Pandey. (2018) Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: A meta-analysis of randomized controlled trials. The Breast Journal 24:3, pages 233-239.
Crossref
Lotte E. Elshof, Marjanka K. Schmidt, Emiel J.Th. Rutgers, Flora E. van Leeuwen, Jelle Wesseling & Michael Schaapveld. (2018) Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ. Annals of Surgery 267:5, pages 952-958.
Crossref
Melissa Pilewskie & Monica Morrow. (2018) Margins in breast cancer: How much is enough?. Cancer 124:7, pages 1335-1341.
Crossref
Rinaa S. Punglia, Wei Jiang, Stuart R. Lipsitz, Melissa E. Hughes, Stuart J. Schnitt, Michael J. Hassett, Larissa Nekhlyudov, Ninah Achacoso, Stephen Edge, Sara H. Javid, Joyce C. Niland, Richard L. Theriault, Yu-Ning Wong & Laurel A. Habel. (2017) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Research and Treatment 167:3, pages 751-759.
Crossref
Susan A. McCloskey & Julia White. 2018. The Breast. The Breast 671 676.e2 .
Melinda S. Epstein, Michael D. Lagios & Melvin J. Silverstein. 2018. The Breast. The Breast 562 575.e4 .
Nicci Owusu-Brackett & Funda Meric-Bernstam. 2018. Atypical Breast Proliferative Lesions and Benign Breast Disease. Atypical Breast Proliferative Lesions and Benign Breast Disease 37 49 .
Todd C. Adams, Nicholas Serrano, Christopher Chipko & Douglas W. Arthur. 2018. Diagnosis and Management of Breast Tumors. Diagnosis and Management of Breast Tumors 113 147 .
Andrea C. Lo, Robert Olson, Deb Feldman-Stewart, Pauline T. Truong, Christina Aquino-Parsons, Joan L. Bottorff & Hannah Carolan. (2017) A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ. American Journal of Clinical Oncology 40:6, pages 574-581.
Crossref
Li Wang, Yaoxiong Xia, Dequan Liu, Yueqin Zeng, Li Chang, Lan Li, Yu Hou, Lv Ge, Wenhui Li & Zhijie Liu. (2017) Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma in situ patients: a network meta-analysis . Oncotarget 8:45, pages 79257-79269.
Crossref
M.J. Cambra, B. Farrús, F. Moreno, Ll Anglada, M. Arenas, R. Ballester, J. Casals, M. Cusidó, V. García, C. Gutiérrez, M. Mollà, A. Pedro, V. Reyes & X. Sanz. (2017) Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow up. The Breast 35, pages 196-202.
Crossref
Samantha Barbour, Julie Moore, Nathan Dunn, Rachel Effeney, Hazel Harden, Alexandra McCarthy, Euan Walpole & Margot Lehman. (2017) Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade. The Breast 35, pages 169-176.
Crossref
C Wadsten, H Garmo, I Fredriksson, M Sund & F Wärnberg. (2017) Risk of death from breast cancer after treatment for ductal carcinoma in situ . British Journal of Surgery 104:11, pages 1506-1513.
Crossref
Per Karlsson. (2017) Postoperative radiotherapy after DCIS: Useful for whom?. The Breast 34, pages S43-S46.
Crossref
Oriana Petruolo & Monica Morrow. (2017) New Guidelines on the Adequacy of Lumpectomy Margin Width in Patients with Ductal Carcinoma In Situ. Current Breast Cancer Reports 9:2, pages 122-128.
Crossref
Alessandra Mele, Pritesh Mehta, Priscilla J. Slanetz, Alexander Brook, Abram Recht & Ranjna Sharma. (2016) Breast-Conserving Surgery Alone for Ductal Carcinoma In Situ: Factors Associated with Increased Risk of Local Recurrence. Annals of Surgical Oncology 24:5, pages 1221-1226.
Crossref
Michael S Toss, Sarah E Pinder, Andrew R Green, Jeremy Thomas, David A L Morgan, John F R Robertson, Ian O Ellis & Emad A Rakha. (2017) Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins? . Histopathology 70:5, pages 681-692.
Crossref
Carlos Martínez-Pérez, Arran K. Turnbull, Gregory E. Ekatah, Laura M. Arthur, Andrew H. Sims, Jeremy S. Thomas & J. Michael Dixon. (2017) Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast. Cancer Treatment Reviews 55, pages 163-172.
Crossref
Randi Ryan, Ossama Tawfik, Roy A. Jensen & Shrikant Anant. 2017. Approaches to Understanding Breast Cancer. Approaches to Understanding Breast Cancer 33 80 .
Beryl McCormick. 2017. Breast Cancer. Breast Cancer 631 635 .
Helena Sackey, Miao Hui, Kamila Czene, Helena Verkooijen, Gustaf Edgren, Jan Frisell & Mikael Hartman. (2016) The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden. Breast Cancer Research 18:1.
Crossref
Monica MorrowKimberly J. Van ZeeLawrence J. SolinNehmat HoussamiMariana Chavez-MacGregorJay R. HarrisJanet HortonShelley HwangPeggy L. JohnsonM. Luke MarinovichStuart J. SchnittIrene WapnirMeena S. Moran. (2016) Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Journal of Clinical Oncology 34:33, pages 4040-4046.
Crossref
Monica Morrow, Kimberly J. Van Zee, Lawrence J. Solin, Nehmat Houssami, Mariana Chavez-MacGregor, Jay R. Harris, Janet Horton, Shelley Hwang, Peggy L. Johnson, M. Luke Marinovich, Stuart J. Schnitt, Irene Wapnir & Meena S. Moran. (2016) Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. Annals of Surgical Oncology 23:12, pages 3801-3810.
Crossref
John R Benson, Ismail Jatoi & Masakazu Toi. (2016) Treatment of low-risk ductal carcinoma in situ: is nothing better than something?. The Lancet Oncology 17:10, pages e442-e451.
Crossref
Monica Morrow, Kimberly J. Van Zee, Lawrence J. Solin, Nehmat Houssami, Mariana Chavez-MacGregor, Jay R. Harris, Janet Horton, Shelley Hwang, Peggy L. Johnson, M. Luke Marinovich, Stuart J. Schnitt, Irene Wapnir & Meena S. Moran. (2016) Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ. Practical Radiation Oncology 6:5, pages 287-295.
Crossref
Ozer Algan, Yan D. Zhao & Terence Herman. (2016) Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer. Clinical Breast Cancer 16:4, pages e99-e106.
Crossref
Sophie Frank, Axelle Dupont, Luis Teixeira, Raphaël Porcher, Anne De Roquancourt, Sylvie Giacchetti, Marc Espié & Caroline Cuvier. (2016) Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women. The Breast 25, pages 51-56.
Crossref
Michael J. Hassett, Wei Jiang, Laurel A. Habel, Larissa Nekhlyudov, Ninah Achacoso, Luana Acton, Stuart J. Schnitt, Deb Schrag & Rinaa S. Punglia. (2016) Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Research and Treatment 155:3, pages 541-549.
Crossref
Jia-Min B Pang, Kylie L Gorringe & Stephen B Fox. (2016) Ductal carcinoma in situ - update on risk assessment and management . Histopathology 68:1, pages 96-109.
Crossref
Ian H. Kunkler. 2016. Management of Breast Diseases. Management of Breast Diseases 221 228 .
Dean A. Shumway, Aaron Sabolch & Reshma Jagsi. 2020. Controversies in Radiation Oncology. Controversies in Radiation Oncology 1 43 .
Elissa M. Ozanne, Katharine H. Schneider, Djøra Soeteman, Natasha Stout, Deborah Schrag, Michael Fordis & Rinaa S. Punglia. (2015) onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Research and Treatment 154:1, pages 181-190.
Crossref
D. Tiberi, T. Hijal & M. Yassa. (2015) Radiothérapie externe hypofractionnée du cancer du sein localisé : où en est-on ?. Cancer/Radiothérapie 19:6-7, pages 426-430.
Crossref
Lotte E. Elshof, Konstantinos Tryfonidis, Leen Slaets, A. Elise van Leeuwen-Stok, Victoria P. Skinner, Nicolas Dif, Ruud M. Pijnappel, Nina Bijker, Emiel J.Th. Rutgers & Jelle Wesseling. (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study. European Journal of Cancer 51:12, pages 1497-1510.
Crossref
R. Geiss, L. Cabel, E. Touboul, J.P. Lefranc, É. Daraï, B. Lauratet, L. Monnier, S. Haberer-Guillerm, F. Deluen, M. Schlienger & F. Huguet. (2015) Carcinomes canalaires in situ du sein traités par chirurgie conservatrice et irradiation avec complément dans le lit opératoire. Cancer/Radiothérapie 19:3, pages 175-179.
Crossref
Alison Hainsworth, Beverley Fosh, Wendy Raymond, Michael Eaton & William McLeay. (2015) Ductal carcinoma in situ: breast-conserving surgery without radiotherapy. ANZ Journal of Surgery 85:4, pages 245-248.
Crossref
Beryl McCormickKathryn WinterClifford HudisHenry Mark KuererEileen RakovitchBarbara L. SmithNour SneigeJennifer MoughanAmit ShahIsabelle GermainAlan C. HartfordAfshin RashtianEleanor M. WalkerAlbert YuenEric A. StromJeannette L. WilcoxLaura A. VallowWilliam SmallJrJrAnthony T. PuKevin KerlinJulia White. (2015) RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation. Journal of Clinical Oncology 33:7, pages 709-715.
Crossref
Melvin J. Silverstein & Michael D. Lagios. (2015) Treatment Selection for Patients with Ductal Carcinoma In Situ (DCIS) of the Breast Using the University of Southern California/Van Nuys (USC/VNPI) Prognostic Index. The Breast Journal 21:2, pages 127-132.
Crossref
Michael D. Lagios & Melvin J. Silverstein. (2015) Ductal Carcinoma In Situ: Recent History and Areas of Controversy. The Breast Journal 21:1, pages 21-26.
Crossref
Amelia Tower, Shivani Duggal & Thomas B. Julian. (2015) Boost Radiotherapy for the Treatment of Ductal Carcinoma In Situ Remains Controversial. Breast Diseases: A Year Book Quarterly 26:1, pages 25-27.
Crossref
Jessica M. Bensenhaver. 2015. Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer. Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer 85 90 .
Melissa Pilewskie & Monica Morrow. 2015. Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer. Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer 67 83 .
Sarah M. DeSnyder & Kelly K. Hunt. 2015. Breast Cancer Screening and Diagnosis. Breast Cancer Screening and Diagnosis 393 409 .
Fredrik WärnbergHans GarmoStefan EmdinVeronica HedbergLinda AdwallKerstin SandelinAnita RingbergPer KarlssonLars-Gunnar ArnessonHarald AndersonKarin JirströmLars Holmberg. (2014) Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial. Journal of Clinical Oncology 32:32, pages 3613-3618.
Crossref
Caprice C. Greenberg, Laurel A. Habel, Melissa E. Hughes, Larissa Nekhlyudov, Ninah Achacoso, Luana Acton, Deborah Schrag, Wei Jiang, Stephen Edge, Jane C. Weeks & Rinaa S. Punglia. (2014) Characterization and Treatment of Local Recurrence Following Breast Conservation for Ductal Carcinoma In Situ. Annals of Surgical Oncology 21:12, pages 3766-3773.
Crossref
Wendy A Woodward, Nour Sneige, Kathryn Winter, Henry Mark Kuerer, Clifford Hudis, Eileen Rakovitch, Barbara L Smith, Lori J Pierce, Isabelle Germano, Anthony T Pu, Eleanor M Walker, David Lawrence Grisell, Julia R White & Beryl McCormick. (2014) Web based pathology assessment in RTOG 98-04. Journal of Clinical Pathology 67:9, pages 777-780.
Crossref
Bruno Cutuli, Jacques Bernier & Philip Poortmans. (2014) Radiotherapy in DCIS, an underestimated benefit?. Radiotherapy and Oncology 112:1, pages 1-8.
Crossref
Jin Hee Kim, Doo Ho Choi, Won Park, Seung Do Ahn, Su Ssan Kim, Sung Whan Ha, Kyubo Kim, Yong Bae Kim, Ji Woon Yea, Min Kyu Kang, Kyung Hwan Shin, Dong Won Kim, Ji Hae Lee & Chang-Ok Suh. (2014) Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04). Breast Cancer Research and Treatment 146:2, pages 341-345.
Crossref
Fernando A. Angarita, Ashlie Nadler, Siham Zerhouni & Jaime Escallon. (2014) Perioperative measures to optimize margin clearance in breast conserving surgery. Surgical Oncology 23:2, pages 81-91.
Crossref
Fuh Yong Wong, Fuqiang Wang, John Ju Chen, Chiew Har Tan & Puay Hoon Tan. (2014) Outcomes of Low-Risk Ductal Carcinoma In Situ in Southeast Asian Women Treated With Breast Conservation Therapy. International Journal of Radiation Oncology*Biology*Physics 88:5, pages 998-1003.
Crossref
E. Karlsson, K. Sandelin, J. Appelgren, W. Zhou, K. Jirström, J. Bergh & F. Wärnberg. (2014) Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events. European Journal of Cancer 50:3, pages 517-524.
Crossref
John Bartlett, Sharon Nofech-Moses & Eileen Rakovitch. (2014) Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Management?. Clinical Chemistry 60:1, pages 60-67.
Crossref
Nicola L.P. Barnes & Nigel J. Bundred. 2014. Breast Surgery. Breast Surgery 179 198 .
R. Souchon, M.-L. Sautter-Bihl, F. Sedlmayer, W. Budach, J. Dunst, P. Feyer, R. Fietkau, W. Haase, W. Harms, F. Wenz & R. Sauer. (2013) DEGRO practical guidelines: radiotherapy of breast cancer IIDEGRO-Leitlinien für die Radiotherapie des Mammakarzinoms II. Strahlentherapie und Onkologie 190:1, pages 8-16.
Crossref
Melvin J. Silverstein & Michael D. Lagios. 2014. Breast Cancer. Breast Cancer 269 311 .
Lara Hathout, Tarek Hijal, Valérie Théberge, Bernard Fortin, Horia Vulpe, Jean-Charles Hogue, Christine Lambert, Houda Bahig, Louise Provencher, Peter Vavassis & Michael Yassa. (2013) Hypofractionated Radiation Therapy for Breast Ductal Carcinoma In Situ. International Journal of Radiation Oncology*Biology*Physics 87:5, pages 1058-1063.
Crossref
Sreekumar Sundara Rajan, Rashmi Verma, Abeer M. Shaaban, Nisha Sharma, Barbara Dall & Mark Lansdown. (2013) Palpable Ductal Carcinoma in Situ: Analysis of Radiological and Histological Features of a Large Series With 5-Year Follow-Up. Clinical Breast Cancer 13:6, pages 486-491.
Crossref
Annabel Goodwin, Sharon Parker, Davina Ghersi & Nicholas Wilcken. (2013) Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews.
Crossref
Mila DonkerSaskia LitièreGustavo WerutskyJean-Pierre JulienIan S. FentimanRoberto AgrestiPhilippe RouanetChristine Tunon de LaraHarry BartelinkNicole DuezEmiel J.T. RutgersNina Bijker. (2013) Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial. Journal of Clinical Oncology 31:32, pages 4054-4059.
Crossref
Andrea M. Abbott, Pamela R. Portschy, Chung Lee, Chap T. Le, Linda K. Han, Tara Washington, Michael Kinney, Margit Bretzke & Todd M. Tuttle. (2013) Prospective Multicenter Trial Evaluating Balloon-Catheter Partial-Breast Irradiation for Ductal Carcinoma in Situ. International Journal of Radiation Oncology*Biology*Physics 87:3, pages 494-498.
Crossref
R. S. Punglia, S. J. Schnitt & J. C. Weeks. (2013) Treatment of Ductal Carcinoma In Situ After Excision: Would a Prophylactic Paradigm Be More Appropriate?. JNCI Journal of the National Cancer Institute 105:20, pages 1527-1533.
Crossref
Anita R. Skandarajah & G. Bruce Mann. (2013) Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS. The Surgeon 11:5, pages 278-285.
Crossref
Tonya M. Martin-Dunlap, Amy E. Cyr, Fatema Al Mushawah, Feng Gao & Julie A. Margenthaler. (2013) Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?. Journal of Surgical Research 184:1, pages 228-233.
Crossref
Beryl McCormick. (2013) Radiation Therapy for Duct Carcinoma in Situ. Hematology/Oncology Clinics of North America 27:4, pages 673-686.
Crossref
A. Guerrieri-Gonzaga, M. Lazzeroni, E. Botteri, D. Serrano, N. Rotmensz, M.-C. Varricchio, M. Cazzaniga, G. Bollani, S. Mora, C. Montefrancesco, G. Pruneri, G. Viale, M. Intra, V. Galimberti, A. Goldhirsch, V. Bagnardi, B. Bonanni & A. DeCensi. (2013) Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study. Annals of Oncology 24:7, pages 1859-1866.
Crossref
Eileen Rakovitch, Steven A. Narod, Sharon Nofech-Moses, Wedad Hanna, Deva Thiruchelvam, Refik Saskin, Carole Taylor, Alan Tuck, Bruce Youngson, Naomi Miller, Susan J. Done, Sandip Sengupta, Leela Elavathil, Prashant A. Jani, Michel Bonin, Stephanie Metcalfe & Lawrence Paszat. (2013) Impact of Boost Radiation in the Treatment of Ductal Carcinoma In Situ: A Population-Based Analysis. International Journal of Radiation Oncology*Biology*Physics 86:3, pages 491-497.
Crossref
Stanimira Krotneva, Kristen Reidel, Mohammed Nassif, Nora Trabulsi, Nancy Mayo, Robyn Tamblyn & Ari N. Meguerditchian. (2013) Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study. Breast Cancer Research and Treatment 140:2, pages 397-405.
Crossref
I. Meattini, L. Livi, D. Franceschini, C. Saieva, F. Meacci, L. Marrazzo, B. Bendinelli, V. Scotti, C. De Luca Cardillo, J. Nori, L. Sanchez, L. Orzalesi, P. Bonomo, D. Greto, M. Bucciolini, S. Bianchi & G. Biti. (2013) Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients. European Journal of Surgical Oncology (EJSO) 39:6, pages 613-618.
Crossref
Djøra I. Soeteman, Natasha K. Stout, Elissa M. Ozanne, Caprice Greenberg, Michael J. Hassett, Deborah Schrag & Rinaa S. Punglia. (2013) Modeling the Effectiveness of Initial Management Strategies for Ductal Carcinoma In Situ. JNCI: Journal of the National Cancer Institute 105:11, pages 774-781.
Crossref
S. Masson & A. Bahl. (2013) The Management of Ductal Carcinoma in Situ: Current Controversies and Future Directions. Clinical Oncology 25:5, pages 275-282.
Crossref
Richard J. Bleicher. (2013) Ductal Carcinoma in Situ. Surgical Clinics of North America 93:2, pages 393-410.
Crossref
L Holmberg, Y N S Wong, L Tabár, A Ringberg, P Karlsson, L-G Arnesson, K Sandelin, H Anderson, H Garmo & S Emdin. (2013) Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. British Journal of Cancer 108:4, pages 812-819.
Crossref
N. Bijker, M. Donker, J. Wesseling, G. J. den Heeten & E. J. Th. Rutgers. (2012) Is DCIS Breast Cancer, and How Do I Treat it?. Current Treatment Options in Oncology 14:1, pages 75-87.
Crossref
Wei Wang. (2013) Radiotherapy in the management of early breast cancer. Journal of Medical Radiation Sciences 60:1, pages 40-46.
Crossref
Wenjing Zhou, Christine Johansson, Karin Jirström, Anita Ringberg, Carl Blomqvist, Rose-Marie Amini, Marie-Louise Fjallskog & Fredrik Wärnberg. (2013) A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ . International Journal of Breast Cancer 2013, pages 1-8.
Crossref
S. Duggal, J. Robin, A. Tower & T.B. Julian. (2013) Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients. Breast Diseases: A Year Book Quarterly 24:4, pages 354-356.
Crossref
Werner Böcker. 2013. Pathologie. Pathologie 239 250 .
H. Hof, U. Freund & W. Harms. 2013. Strahlentherapie. Strahlentherapie 517 555 .
Nils D. Arvold, Rinaa S. Punglia, Melissa E. Hughes, Wei Jiang, Stephen B. Edge, Sara H. Javid, Christine Laronga, Joyce C. Niland, Richard L. Theriault, Jane C. Weeks, Yu‐Ning Wong, Sandra J. Lee & Michael J. Hassett. (2012) Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer 118:24, pages 6022-6030.
Crossref
Nicola LP Barnes, Kathryn E Williams & Nigel J Bundred. (2012) The management of preinvasive breast cancer. Breast Cancer Management 1:2, pages 135-142.
Crossref
Luisa C. Kropcho, Shawn T. Steen, Alice P. Chung, Myung-Shin Sim, Daniel L. Kirsch & Armando E. Giuliano. (2012) Preoperative Breast MRI in the Surgical Treatment of Ductal Carcinoma In Situ. The Breast Journal 18:2, pages 151-156.
Crossref
Min YiFunda Meric-BernstamHenry M. KuererElizabeth A. MittendorfIsabelle BedrosianAnthony LucciRosa F. HwangJaime R. CrowSheng LuoKelly K. Hunt. (2012) Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision. Journal of Clinical Oncology 30:6, pages 600-607.
Crossref
Philip Wong, Christine Lambert, Ramanakumar V. Agnihotram, Marc David, Marie Duclos & Carolyn R. Freeman. (2012) Ductal Carcinoma in Situ—The Influence of the Radiotherapy Boost on Local Control. International Journal of Radiation Oncology*Biology*Physics 82:2, pages e153-e158.
Crossref
Rinaa S. Punglia, Harold J. Burstein & Jane C. Weeks. (2011) Radiation therapy for ductal carcinoma in situ. Cancer 118:3, pages 603-611.
Crossref
Csaba Polgár, Tibor Major & János Fodor. (2012) Modern radiotherapy after breast-conserving surgery. Orvosi Hetilap 153:2, pages 45-55.
Crossref
Olivier Riou, Claire Lemanski, Vanessa Guillaumon, Olivier Lauche, Pascal Fenoglietto, Jean-Bernard Dubois & David Azria. (2012) Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ . International Journal of Surgical Oncology 2012, pages 1-5.
Crossref
Kelly Lambert, Neill Patani & Kefah Mokbel. (2012) Ductal Carcinoma In Situ : Recent Advances and Future Prospects . International Journal of Surgical Oncology 2012, pages 1-11.
Crossref
Meena S. Moran, Harrison X. Bai, Eleanor E. R. Harris, Douglas W. Arthur, Lisa Bailey, Jennifer R. Bellon, Lisa Carey, Sharad Goyal, Michele Y. Halyard, Kathleen C. Horst, Shannon M. MacDonald & Bruce G. Haffty. (2012) ACR Appropriateness Criteria® Ductal Carcinoma in Situ. The Breast Journal 18:1, pages 8-15.
Crossref
Moïse Namer, Michel Héry, Marc Spielmann, Joseph Gligorov & Frédérique Penault-LlorcaB. Cutuli. 2012. Cancer du sein. Cancer du sein 609 633 .
Sanaz A. Jansen. (2011) Ductal Carcinoma In Situ: Detection, Diagnosis, and Characterization with Magnetic Resonance Imaging. Seminars in Ultrasound, CT and MRI 32:4, pages 306-318.
Crossref
Sevilay Altintas, Jerome Toussaint, Virginie Durbecq, Kathleen Lambein, Manon T. Huizing, Denis Larsimont, Eric Van Marck, Jan B. Vermorken, Wiebrem A. Tjalma & Christos Sotiriou. (2011) Fine Tuning of the Van Nuys Prognostic Index (VNPI) 2003 by Integrating the Genomic Grade Index (GGI): New Tools for Ductal Carcinoma In Situ (DCIS). The Breast Journal 17:4, pages 343-351.
Crossref
Gabriel Farante, Stefano Zurrida, Viviana Galimberti, Paolo Veronesi, Giuseppe Curigliano, Alberto Luini, Aron Goldhirsch & Umberto Veronesi. (2010) The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy. Breast Cancer Research and Treatment 128:2, pages 369-378.
Crossref
Neill Patani, Yazan Khaled, Sara Al Reefy & Kefah Mokbel. (2011) Ductal carcinoma in-situ: An update for clinical practice. Surgical Oncology 20:1, pages e23-e31.
Crossref
Alice Ho, Anuj Goenka, Nicole Ishill, Kimberly Van Zee, Amanda McLane, Anne Marie Gonzales, Lee Tan, Hiram Cody, Simon Powell & Beryl McCormick. (2011) The effect of age in the outcome and treatment of older women with ductal carcinoma in situ. The Breast 20:1, pages 71-77.
Crossref
Elaine S. Wai, Mary L. Lesperance, Cheryl S. Alexander, Pauline T. Truong, Patrizia Moccia, Matthew Culp, Jennifer Lindquist & Ivo A. Olivotto. (2010) Predictors of Local Recurrence in a Population-Based Cohort of Women with Ductal Carcinoma In Situ Treated with Breast Conserving Surgery Alone. Annals of Surgical Oncology 18:1, pages 119-124.
Crossref
Jacqueline S. Jeruss, Henry M. Kuerer, Peter D. Beitsch, Frank A. Vicini & Martin Keisch. (2010) Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. Annals of Surgical Oncology 18:1, pages 65-71.
Crossref
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman & William D George. (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. The Lancet Oncology 12:1, pages 21-29.
Crossref
Christelle Faure. 2011. Maladies du sein. Maladies du sein 117 120 .
Marie-Pierre Sunyach. 2011. Maladies du sein. Maladies du sein 107 116 .
Csaba Polgár. 2011. Breast Cancer, a Heterogeneous Disease Entity. Breast Cancer, a Heterogeneous Disease Entity 211 240 .
Elaine S. Wai, Mary L. Lesperance, Cheryl S. Alexander, Pauline T. Truong, Matthew Culp, Patricia Moccia, Jennifer F. Lindquist & Ivo A. Olivotto. (2010) Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 117:1, pages 54-62.
Crossref
Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje & Fredrik Wärnberg. (2010) Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study. BMC Cancer 10:1.
Crossref
Laura G. Estévez, Isabel Álvarez, Miguel Ángel Seguí, Monserrat Muñoz, Mireia Margelí, Cristina Miró, Carmen Rubio, Ana Lluch & Ignasi Tusquets. (2010) Current perspectives of treatment of ductal carcinoma in situ. Cancer Treatment Reviews 36:7, pages 507-517.
Crossref
. (2010) Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast. JNCI Monographs 2010:41, pages 162-177.
Crossref
V. White, M. Pruden, P. Kitchen, E. Villanueva & B. Erbas. (2010) The impact of publication of Australian treatment recommendations for DCIS on clinical practice: A population-based, “before-after” study. European Journal of Surgical Oncology (EJSO) 36:10, pages 949-956.
Crossref
Benjamin D. Smith & Thomas A. Buchholz. 2011. Practical Geriatric Oncology. Practical Geriatric Oncology 63 86 .
Csaba Polgár, András Csejtei, Gabriella Gábor, László Landherr, László Mangel, Árpád Mayer, György Németh & János Fodor. (2010) Sugárterápiás irányelvek. Magyar Onkológia 54:3, pages 257-265.
Crossref
Sevilay Altintas, Manon T. Huizing, Eric Marck, Jan B. Vermorken & Wiebren A. Tjalma. (2010) Ductal carcinoma in situ: a challenging disease. Oncology Reviews 4:3, pages 191-202.
Crossref
Udo RudloffLindsay M. JacksJessica I. GoldbergChristine A. WynveenEdi BrogiSujata PatilKimberly J. Van Zee. (2010) Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ. Journal of Clinical Oncology 28:23, pages 3762-3769.
Crossref
Aslaug Aamodt Muggerud, Michael Hallett, Hilde Johnsen, Kristine Kleivi, Wenjing Zhou, Simin Tahmasebpoor, Rose-Marie Amini, Johan Botling, Anne-Lise Børresen-Dale, Therese Sørlie & Fredrik Wärnberg. (2010) Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer . Molecular Oncology 4:4, pages 357-368.
Crossref
H. Sackey, K. Sandelin, J. Frisell, M. Wickman & Y. Brandberg. (2010) Ductal carcinoma in situ of the breast. Long-term follow-up of health-related quality of life, emotional reactions and body image. European Journal of Surgical Oncology (EJSO) 36:8, pages 756-762.
Crossref
Loren L. Rourke & Kelly K. Hunt. (2010) Avoiding Radiation After Breast-Conserving Surgery for Ductal Carcinoma In Situ of the Breast. Annals of Surgery 251:4, pages 592-594.
Crossref
Udo Rudloff, Edi Brogi, Anne S. Reiner, Jessica I. Goldberg, Julia P. Brockway, Christine A. Wynveen, Beryl McCormick, Sujata Patil & Kimberly J. Van Zee. (2010) The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy. Annals of Surgery 251:4, pages 583-591.
Crossref
Janina Kulka. (2010) Pathological aspects of in situ carcinoma/intraepithelial neoplasia of the breast. Orvosi Hetilap 151:2, pages 45-53.
Crossref
Aimee M. Crago, Michelle Azu, Shannon Tierney & Monica Morrow. (2010) Randomized Clinical Trials in Breast Cancer. Surgical Oncology Clinics of North America 19:1, pages 33-58.
Crossref
L.W. Cuttino. (2010) American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis—4-year data in 194 treated lesions. Breast Diseases: A Year Book Quarterly 21:1, pages 60-62.
Crossref
Robin M. Ciocca & Monica Morrow. 2010. Management of Breast Diseases. Management of Breast Diseases 201 225 .
Michael D. Lagios. 2011. Breast Surgical Techniques and Interdisciplinary Management. Breast Surgical Techniques and Interdisciplinary Management 623 631 .
Laurel A Habel, Ninah S Achacoso, Reina Haque, Larissa Nekhlyudov, Suzanne W Fletcher, Stuart J Schnitt, Laura C Collins, Ann M Geiger, Balaram Puligandla, Luana Acton & Charles P QuesenberryJrJr. (2009) Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Research 11:6.
Crossref
Holger Hof. (2009) Adjuvante Strahlentherapie des MammakarzinomsAdjuvant Radiotherapy of Breast Cancer. Onkopipeline 2:4, pages 158-163.
Crossref
Nicolai Maass, Özkan Alkasi, Maret Bauer, Walter Jonat, R. Souchon & Ivo Meinhold-Heerlein. (2009) Actual management of ductal carcinoma in situ of the breast. Archives of Gynecology and Obstetrics 280:5, pages 699-705.
Crossref
Annabel Goodwin, Sharon Parker, Davina Ghersi & Nicholas Wilcken. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Martin Keisch, Frank Vicini, Peter Beitsch, Coral Quiet, Angela Keleher, Delia Garcia, Howard Snider, Mark Gittleman, Victor Zannis & Henry Kuerer. (2009) American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis—4-year data in 194 treated lesions. The American Journal of Surgery 198:4, pages 505-507.
Crossref
Annabel Goodwin, Sharon Parker, Davina Ghersi & Nicholas Wilcken. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Miklós Kásler, Csaba Polgár & János Fodor. (2009) Current status of treatment for early-stage invasive breast cancer. Orvosi Hetilap 150:22, pages 1013-1021.
Crossref
B Cutuli, C Lemanski, A Fourquet, B de Lafontan, S Giard, A Meunier, R Pioud-Martigny, F Campana, H Marsiglia, S Lancrenon, E Mery, F Penault-Llorca, E Fondrinier & C Tunon de Lara. (2009) Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. British Journal of Cancer 100:7, pages 1048-1054.
Crossref
Aliana Guerrieri-Gonzaga, Edoardo Botteri, Nicole Rotmensz, Fabio Bassi, Mattia Intra, Davide Serrano, Giuseppe Renne, Alberto Luini, Massimiliano Cazzaniga, Aaron Goldhirsch, Marco Colleoni, Giuseppe Viale, Giovanni Ivaldi, Vincenzo Bagnardi, Matteo Lazzeroni, Andrea Decensi, Umberto Veronesi & Bernardo Bonanni. (2009) Ductal Intraepithelial Neoplasia: Postsurgical Outcome for 1,267 Women Cared for in One Single Institution over 10 Years. The Oncologist 14:3, pages 201-212.
Crossref
Michael Lagios. (2009) Therapeutic Decisions for Ductal Carcinoma In Situ: A Gordian Knot. The Breast Journal 15:2, pages 117-119.
Crossref
Kimberly S. Keene & Jennifer F. De Los Santos. (2009) What Influence Does Patient Age Have on DCIS Recurrence?. Breast Diseases: A Year Book Quarterly 20:1, pages 35-37.
Crossref
Laurie W. Cuttino & Frank A. Vicini. 2009. The Breast. The Breast 1069 1076 .
Melvin J. Silverstein. 2009. The Breast. The Breast 927 952 .
Philip Meijnen, Kenneth G. Gilhuijs & Emiel J.Th. Rutgers. (2008) The effect of margins on the clinical management of ductal carcinoma in situ of the breast. Journal of Surgical Oncology 98:8, pages 579-584.
Crossref
Ian S Fentiman. (2008) Ductal Carcinoma In Situ of the Breast: One Reason for Considering Radiotherapy as Part of Breast-Conservation Therapy . Women's Health 4:6, pages 579-581.
Crossref
Melvin J Silverstein. (2008) Ductal Carcinoma In Situ of the Breast: 11 Reasons to Consider Treatment with Excision Alone . Women's Health 4:6, pages 565-577.
Crossref
D. Azria, H. Auvray, I. Barillot, P. Baumann, A. Benyoucef, F. Bons-Rosset, P. Bontemps, C. Bourgier, C. Breton-Callu, D. Cowen, J. Cretin, B. Delalande, F. Denis, S. Ellis, Z. Gaci, J.-M. Hannoun-Lévy, A. Hasbini, C. Hennequin, J.-L. Lagrange, E. Lartigau, I. Latorzeff, M. Le Blanc-Onfroy, I. Lecouillard, C. Lemanski, C. Levy, P. Maingon, C. Marchal, A. Monnier, O. Pradier, S. Racadot, P. Romestaing, D. Serin, J.-M. Simon, E. Teyssier, A. Tallet, A. Tolédano & Y. Belkacémi. (2008) Radiothérapie des carcinomes canalaires in situ : impact du complément d’irradiation du lit tumoral. Cancer/Radiothérapie 12:6-7, pages 571-576.
Crossref
George H. Sakorafas, David R. Farley & George Peros. (2008) Recent advances and current controversies in the management of DCIS of the breast. Cancer Treatment Reviews 34:6, pages 483-497.
Crossref
Lisa E. Guerra, Robina M. Smith, Anna Kaminski, Michael D. Lagios & Melvin J. Silverstein. (2008) Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ. The American Journal of Surgery 196:4, pages 552-555.
Crossref
Csaba Polgár, Zsolt Orosz, Zsuzsanna Kahán, Gabriella Gábor, Nóra Jani, Gábor Cserni, Janaki Hadijev, Janina Kulka, Zoltán Sulyok, Gábor Boross, György Lázár, Zsolt László, Csaba Diczházi, Nóra Udvarhelyi, Éva Szabó, Zoltán Péntek, Tibor Major & János Fodor. (2008) In situ duktális emlőkarcinóma kombinált sebészi- és sugárkezelése: a magyarországi multicentrikus prospektívCombined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: Preliminary results of the Hungarian multicentric prospective randomised study. Magyar Onkológia 52:3, pages 269-277.
Crossref
D Robinson, L Holmberg & H Møller. (2008) The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. British Journal of Cancer 99:4, pages 611-615.
Crossref
Csaba Polgár, Zsuzsanna Kahán, Zsolt Orosz, Gabriella Gábor, Janaki Hadijev, Gábor Cserni, Janina Kulka, Nóra Jani, Zoltán Sulyok, György Lázár, Gábor Boross, Csaba Diczházi, Éva Szabó, Zsolt László, Zoltán Péntek, Tibor Major & János Fodor. (2008) The Role of Radiotherapy in the Conservative Treatment of Ductal Carcinoma in Situ of the Breast. Pathology & Oncology Research 14:2, pages 179-192.
Crossref
Lars HolmbergHans GarmoBengt GranstrandAnita RingbergLars-Gunnar ArnessonKerstin SandelinPer KarlssonHarald AndersonStefan Emdin. (2008) Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast. Journal of Clinical Oncology 26:8, pages 1247-1252.
Crossref
Martin D. Abeloff, Antonio C. Wolff, Barbara L. Weber, Tal Z. Zaks, Vergilio Sacchini & Beryl McCormick. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1875 1943 .
Gustavo A Viani, Eduardo J Stefano, Sérgio L Afonso, Lígia I De Fendi, Francisco V Soares, Paola G Leon & Flavio S Guimarães. (2007) Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiation Oncology 2:1.
Crossref
Arjan P. Schouten van der Velden, Roel van Vugt, Jos A.A.M. Van Dijck, Jan Willem H. Leer & Theo Wobbes. (2007) Local Recurrences After Different Treatment Strategies for Ductal Carcinoma In Situ of the Breast: A Population-Based Study in the East Netherlands. International Journal of Radiation Oncology*Biology*Physics 69:3, pages 703-710.
Crossref
Jesmin Shafiq, Geoff Delaney & Michael B. Barton. (2007) An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer. Radiotherapy and Oncology 84:1, pages 11-17.
Crossref
Abram Recht. (2007) The weakest link. European Journal of Cancer 43:2, pages 228-230.
Crossref
A. Ringberg, H. Nordgren, S. Thorstensson, I. Idvall, H. Garmo, B. Granstrand, L.G. Arnesson, K. Sandelin, A. Wallgren, H. Anderson, S. Emdin & L. Holmberg. (2007) Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast – Results from the Swedish randomised trial. European Journal of Cancer 43:2, pages 291-298.
Crossref
Monica Morrow & Martin J. O’Sullivan. (2007) The dilemma of DCIS. The Breast 16, pages 59-62.
Crossref
B. Cutuli. 2007. Le cancer du sein. Le cancer du sein 251 272 .
Kefah Mokbel & Bruno Cutuli. (2006) Heterogeneity of ductal carcinoma in situ and its effects on management. The Lancet Oncology 7:9, pages 756-765.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.